|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase II study of G3139, a Bcl-2 antisense oligonucleotide , in combination with dexamethason and thalidomide in relapsed multiple myeloma patients 显示文摘 | Badros AZ Goloubeva O Rapoport AP etal | 2005 | J Clin Oncol2005，23，18： | 1 |
| 2 | Combination im- munotherapy after ASCT for multiple myeloma using MAGE-A3/Poly- ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells显示文摘 | Rapoport AP Aqui NA Stadtmauer EA | 2014 | CIin Cancer Res2014，20，5： | 1 |
| 3 | Phase Ⅱ study of G3139, a Bcl-2 antisense oligonueleotide, in combination with dexamethason and thalidomide in relapsed multiple myeloma patients显示文摘 | Badros AZ Goloubeva Q Rapoport AP | 2005 | J Clin Oncol2005，23，18： | 1 |
| 4 | Phase Ⅱ study of G3139,a Bcl-2 antisense oligonucleotide,in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients显示文摘 | Badros AZ Goloubeva O Rapoport AP | 2005 | J Clin Oncol2005，23，18： | 1 |
| 5 | Autotransplantation for advanced lymphoma and Hodgkin 's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy显示文摘 | Rapoport AP Meisenberg B Sarkodee-Adoo C | 2002 | Bone Marrow Tranplant2002，29，4： | 1 |
| 6 | Autotransplantation for relapsed or refractory non -Hodgkin's lymphoma (NHL):long -tem follow -up and analysis of prognostic factors显示文摘 | Rapoport AP Lifton R Constine LS | 1997 | Bone Marow Transplant1997，19，9： | 1 |
| 7 | Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy显示文摘 | Rapoport AP Meisenberg B Sarkodee-Adoo C | 2002 | Bone Marrow Transplant2002，29，4： | 1 |
| 8 | NY-ESO-l-specific TCR-engineered T ceils medi- ate sustained antigen-specific antitumor effects in mye- loma显示文摘 | Rapoport AP Stadtmaner EA Binder-Scholl GK | 2015 | Nat Med2015，21，18： | 1 |
| 9 | NY-ESO-l-specific TCR-engineered T ceils mediate sustained antigen-specific antitumor effects in myeloma 显示文摘 | RAPOPORT AP STADTMAUER EA BINDER-SCHOLL GK | 2015 | Nat Med2015，21，8： | 1 |
| 10 | Successful treatment of IgG and complement-mediated autoimmune hemolytic anemia with bortezomib and low-dose cyclophosphamide 显示文摘 | Danchaivijitr P Yared J Rapoport AP | 2011 | Am J Hematol2011，86，3： | 1 |
| 11 | Autotransplantation for relapsed or refractory non-Hodgkin's lymphoma(NHL): long-term follow-up and analysis of prognostic factors显示文摘 | Rapoport AP Lifton R Constine LS | 1997 | Bone Marrow Transplant1997，19，9： | 1 |
| 12 | Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants显示文摘 | Rapoport AP Miller Watelet LF Linder T | 1999 | J Clin Oncol1999，17，8： | 1 |
| 13 | Chronic inflamma-tory demyelinating polyneuropathy in non-Hodgkin’s lymphoma显示文摘 | Griggs JJ Commichau CS Rapoport AP | 1997 | Am J Hematol1997，54，： | 1 |
| 14 | Autotransplantation for relapsed or refractory non-Hodgkin' s lymphoma (NHL): long-term follow-up and analysis of prognostic factors 显示文摘 | Rapoport AP Liflon R Constine LS | 1997 | Bone Marrow Transplant1997，19，9： | 1 |
| 15 | Phase Ⅱ study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients显示文摘 | Badros AZ Goloubeva O Rapoport AP | 2005 | J Clin Oncol2005，23，18： | 1 |
| 16 | An analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants 显示文摘 | Rapoport AP Miller WLF Linder T | 1999 | J Clin Oncol1999，17，8： | 1 |
| 17 | Phase Ⅱ study of G3139,a Bcl-2 antisense oligonucleotide,in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients显示文摘 | Badros AZ Goloubeva O Rapoport AP | 2005 | J Clin Oncol2005，23，18： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员